Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains
about
Quadrupling muscle mass in mice by targeting TGF-beta signaling pathwaysLatent myostatin has significant activity and this activity is controlled more efficiently by WFIKKN1 than by WFIKKN2WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activityAgrin binds BMP2, BMP4 and TGFbeta1Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2Regulation of muscle growth by multiple ligands signaling through activin type II receptors.Both WFIKKN1 and WFIKKN2 have high affinity for growth and differentiation factors 8 and 11Myostatin from the heart: local and systemic actions in cardiac failure and muscle wastingDelivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.Myostatin: expanding horizonsPharmacology of manipulating lean body massThe structure of myostatin:follistatin 288: insights into receptor utilization and heparin bindingMethylome-wide Association Study of Atrial Fibrillation in Framingham Heart StudyShort-term endurance training results in a muscle-specific decrease of myostatin mRNA content in the ratGenetic analysis of the role of proteolysis in the activation of latent myostatinStructural basis for potency differences between GDF8 and GDF11.Systemic myostatin inhibition via liver-targeted gene transfer in normal and dystrophic miceDeep intronic mutation and pseudo exon activation as a novel muscular hypertrophy modifier in cattleProteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic miceInhibin at 90: from discovery to clinical application, a historical reviewGASP/WFIKKN proteins: evolutionary aspects of their functions.Ubiquitous Gasp1 overexpression in mice leads mainly to a hypermuscular phenotype.METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11.Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future InvestigationExtracellular Regulation of Myostatin: A Molecular Rheostat for Muscle Mass.Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinasesElimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality.Role of TGF-β signaling in inherited and acquired myopathies.Alternative binding modes identified for growth and differentiation factor-associated serum protein (GASP) family antagonism of myostatin.The role of myostatin in muscle wasting: an overviewDouble Muscling in Cattle: Genes, Husbandry, Carcasses and Meat.Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay.Molecular and cellular determinants of skeletal muscle atrophy and hypertrophy.Effect of variation in ovine WFIKKN2 on growth traits appears to be gender-dependent.Peroxisome proliferator-activated receptor β/δ induces myogenesis by modulating myostatin activityTargeted mutations in myostatin by zinc-finger nucleases result in double-muscled phenotype in Meishan pigsRole of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway.The therapeutic potential of agents that inactivate myostatin.Myostatin facilitates slow and inhibits fast myosin heavy chain expression during myogenic differentiation.
P2860
1810545c1d0775cbc7e6c6f215398c5597e792392875b3c663ee1410220649008d1a77af0d34d77a39c45cb7d0e56e9be7b2fa784fa663b9a603985e5f229fc67f82c8257c893d308fc1329abf4ef8ba7f58b38464ee4ed2c70179befa9dde6e9452b92983eaff7ba9f26c5e19cd09e04fafc41dbeed035ed873c7342eca34e5af2ee1cd204afa754efef5ecdca6b08007e9b175910d442b36ca2551aaf06482e70e620b08056deb7794913cdb0045d2c776629ef25278a2bfe513c548f601fc7682cb863f27744bf52d378ced296c4bdc86c5eabd2f2236bfa86ab6f764f5a573aceb6eed069cb5e01d04d233d71a76
P248
Q21090110-25606FE7-926D-4B6F-9B50-8D21671062B9Q24297583-B71A3911-F980-4BAB-9C41-353E6AFC185CQ24305801-F381D873-ABD5-4314-967E-FD1FC7BCAAF0Q24315763-1A3E9739-6449-40DF-B23F-12A52290E28EQ24323503-9882BF62-98A5-43E8-8FE5-BEEF98716CD5Q24538732-F3827028-85CF-4AA0-9EC6-ADE6177C296FQ24607839-DD795B53-4AA8-439F-9723-962F1A9227DAQ24609841-93F20D5F-B130-412A-AC6F-D8F5AD82D8F9Q24647245-30891DD3-B84B-4551-A64A-CEF26BFD9C25Q26797484-6B156627-E1BB-41F2-B77D-3113E0513756Q26824503-4849599A-09A2-44A2-8F4D-4859FCE2D546Q27656789-C5EEC257-F6B5-43C9-BABC-3BB63E0F1D13Q28365131-0C2D6040-BE17-43F7-B8C6-1AE3A1C093C9Q28578532-58C7F36F-6754-441F-8E8D-9E61150F88D6Q28592774-CB45FACA-2A8A-4B4D-BDD2-3F2715847216Q31813087-5C5D7C80-7C7F-4FA5-888D-14E80D10727FQ33531816-5AE4E1EB-F8EC-4545-9B05-0899E3CF30FFQ33610303-F6F1AAA2-51EC-4FEE-B618-9ED9E9A89830Q33642619-1251AFD1-35BD-49A6-AA6D-FFECD71AA890Q33881904-37317D3B-90D6-425F-BFA1-4782A6470730Q34204531-6093DB36-F076-423C-B504-B24BBE7CA75CQ34399328-20F8CA93-AC2A-4B6B-9DDF-1DF331199299Q34436785-3FC7C950-3F05-49CC-97AC-64F93779EFAFQ34447001-D28559F5-3C46-42B1-8427-1724111E3507Q34520504-5C758FAC-9D26-432A-B39D-5B7624F94FDBQ34694932-874449AF-8CC6-41FC-A7B2-3337FB7DE568Q34792315-EA652729-4873-440E-9CEB-B09FD794E6E9Q35083601-1F53468F-7F62-4746-8A19-55797A2AF75FQ35166254-0794AE4B-CB44-4ADC-B7E5-F2153B0E6D8FQ35199362-98ECEE50-F203-4BD5-BB9D-2497405D10F1Q35223987-CDAAA72F-72CF-4EA2-B140-50ED8A57518FQ35826856-9C095AC8-0FB1-4FCF-8DF4-D89833B3844BQ35853649-9E0291BF-39DA-4731-94C0-B41E1C8C882BQ35855155-F91CC96B-E809-44D4-8D90-9A3420AB40B3Q35877352-0E410DFF-4106-4AD3-8398-ED855C27B0C5Q35921627-2E54B599-134E-44C2-B2B7-BA37A20C43C4Q36099656-B48D0203-BC5A-4D74-9641-DAC3FC574395Q36213027-778E9E33-AA34-40E6-97AA-BBB9039C6471Q36249879-9AB8E35A-CD5F-4E60-BCFE-B85455391AA5Q36353084-4F72C3C4-2702-41DC-979A-D12E5D7DF5BC
P2860
Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains
description
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Juni 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/06/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/06/01)
@nl
наукова стаття, опублікована в червні 2003
@uk
مقالة علمية (نشرت في يونيو 2003)
@ar
name
Regulation of myostatin in viv ...... ibitor and follistatin domains
@ast
Regulation of myostatin in viv ...... ibitor and follistatin domains
@en
Regulation of myostatin in viv ...... ibitor and follistatin domains
@nl
type
label
Regulation of myostatin in viv ...... ibitor and follistatin domains
@ast
Regulation of myostatin in viv ...... ibitor and follistatin domains
@en
Regulation of myostatin in viv ...... ibitor and follistatin domains
@nl
prefLabel
Regulation of myostatin in viv ...... ibitor and follistatin domains
@ast
Regulation of myostatin in viv ...... ibitor and follistatin domains
@en
Regulation of myostatin in viv ...... ibitor and follistatin domains
@nl
P2093
P921
P356
P1476
Regulation of myostatin in viv ...... ibitor and follistatin domains
@en
P2093
Jennifer J. Hill
Neil M. Wolfman
Rodney M. Hewick
Yongchang Qiu
P304
P356
10.1210/ME.2002-0366
P577
2003-06-01T00:00:00Z